Pharma BD Deal Intelligence
Roche Holding AG / InterMune Inc.
2014 · Acquisition/Merger · $8.3B · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
54
Mixed — partial payoff, real shortfalls.
Roche acquired InterMune for $8.3B for pulmonary fibrosis and respiratory therapeutics.
Key facts
- Announced Aug 24, 2014
- Closed Sep 29, 2014
- Deal value $8.3B
- Deal type Acquisition/Merger
- Therapeutic area Respiratory
- Key assets pirfenidone
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals